Development and validation of FinTox: A new screening tool to assess cancer‐related financial toxicity
FinTox's robust psychometric properties and diagnostic accuracy position it as a reliable tool for detecting financial toxicity. Future research should evaluate its responsiveness to changes over time and integration into clinical workflows.
Authors
- Jessie Han (ORCID: https://orcid.org/0000-0001-6008-4195)
- Hoda Badr (ORCID: https://orcid.org/0000-0002-4549-9111)
- Martha Pritchett Mims
Institutions
- Baylor College of Medicine (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cam4.7306
- Citations
- 8
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 9.03
Funders
- National Cancer Institute